Entity Common Stock, Shares Outstanding of NEUROONE MEDICAL TECHNOLOGIES Corp from 30 Jun 2011 to 12 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2011 to 12 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Entity Common Stock, Shares Outstanding for the quarter ending 12 Dec 2025 was 50,413,148, a 63% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,413,148 +19,571,318 +63% 12 Dec 2025 10-K 17 Dec 2025 2025 FY
Q2 2025 49,999,519 +19,187,639 +62% 12 Aug 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 49,817,835 +22,301,914 +81% 09 May 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 30,841,830 +6,878,983 +29% 13 Dec 2024 10-K 17 Dec 2024 2024 FY
Q2 2024 30,811,880 +6,892,696 +29% 13 Aug 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 27,515,921 +9,954,145 +57% 10 May 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 23,962,847 +7,724,383 +48% 15 Dec 2023 10-K 15 Dec 2023 2023 FY
Q2 2023 23,919,184 +7,709,952 +48% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 17,561,776 +1,368,309 +8.4% 11 May 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 16,238,464 +50,742 +0.31% 20 Dec 2022 10-K 22 Dec 2022 2022 FY
Q2 2022 16,209,232 +4,208,647 +35% 09 Aug 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 16,193,467 +4,238,924 +35% 11 May 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 16,187,722 -6,805,666 -30% 13 Dec 2021 10-K/A 31 May 2022 2021 FY
Q2 2021 12,000,585 -10,051,709 -46% 12 Aug 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 11,954,543 -4,199,579 -26% 13 May 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 22,993,388 +9,296,015 +68% 07 Dec 2020 10-K 09 Dec 2020 2020 FY
Q2 2020 22,052,294 +8,562,090 +63% 10 Aug 2020 10-Q 13 Aug 2020 2020 Q3
Q1 2020 16,154,122 +2,943,357 +22% 08 May 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 13,697,373 +3,820,868 +39% 30 Nov 2019 10-K 20 Dec 2019 2019 FY
Q2 2019 13,490,204 +4,033,699 +43% 09 Aug 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 13,210,765 +5,345,771 +68% 08 May 2019 10-Q 10 May 2019 2019 Q2
Q4 2018 9,876,505 30 Nov 2018 10-KT 18 Mar 2019 2018 FY
Q2 2018 9,456,505 +1,591,511 +20% 08 Aug 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 7,864,994 +2,791,994 +55% 31 Mar 2018 10-K 16 Apr 2018 2017 FY
Q3 2017 7,864,994 +2,791,994 +55% 10 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 7,864,994 +2,791,994 +55% 11 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 5,073,000 0 0% 14 Apr 2017 10-K 17 Apr 2017 2016 FY
Q3 2016 5,073,000 0 0% 14 Nov 2016 10-Q 21 Nov 2016 2016 Q3
Q2 2016 5,073,000 0 0% 18 May 2016 10-Q 23 May 2016 2016 Q1
Q1 2016 5,073,000 0 0% 11 Apr 2016 10-K 14 Apr 2016 2015 FY
Q3 2015 5,073,000 13 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 5,073,000 0 0% 18 May 2015 10-Q 20 May 2015 2015 Q1
Q1 2015 5,073,000 0 0% 31 Mar 2015 10-K 15 Apr 2015 2014 FY
Q4 2014 5,073,000 19 Nov 2014 10-Q 19 Nov 2014 2014 Q3
Q2 2014 5,073,000 0 0% 20 May 2014 10-Q 20 May 2014 2014 Q1
Q1 2014 5,073,000 0 0% 31 Mar 2014 10-K/A 24 Apr 2014 2013 FY
Q3 2013 6,573,000 +1,500,000 +30% 30 Sep 2013 10-Q 15 Nov 2013 2013 Q3
Q2 2013 5,073,000 0 0% 14 Aug 2013 10-Q 15 Aug 2013 2013 Q2
Q1 2013 5,073,000 0 0% 11 Apr 2013 10-K 11 Apr 2013 2012 FY
Q3 2012 5,073,000 +488,000 +11% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 5,073,000 +573,000 +13% 30 Jun 2012 10-Q 15 Aug 2012 2012 Q2
Q1 2012 5,073,000 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 5,073,000 31 Dec 2011 10-K 28 Mar 2012 2011 FY
Q3 2011 4,585,000 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 4,500,000 30 Jun 2011 10-Q/A 06 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.